319.00
+4.25%
Close of 9 Nov 2026, in NOK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medistim A
Its shares trade on Oslo Børs under the ticker MEDI.OL. It has been listed since 28 May 2004. In the fiscal year to 31 December 2025, it reported revenue of NOK 699.8m and net income of NOK 159.2m. At that date it held total assets of NOK 660.6m and shareholders' equity of NOK 468.4m.
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 28 May 2004
- Employees
- 112
- Website
- medistim.com ↗
Leadership
Pay as last reported
- Mr. Oyvin BroymerChairman of the Board, since 2000NOK 250,000
- Ms. Kari KrogstadPresident, Chief Executive OfficerNOK 3.0m
- Mr. Thomas JakobsenChief Financial OfficerNOK 1.8m
- Mr. Mike FarbelowPresident of Medistim USA, Inc.NOK 1.9m
- Mr. Ole RobsrudManaging Director Medistim Norge ASNOK 1.4m
- Mr. Roger MorbergVice President SalesNOK 1.6m
- Ms. Haege Krogh WetterhusVice President MarketingNOK 1.3m
- Mr. Helge BorslidVice President - Manufacturing
- Ms. Tone VeitebergVice President Regulatory Affairs & Quality AssuranceNOK 1.1m
- Mr. Anne WaalerVice President - Medical Department
- Mr. Erik SwensenVice President Research and DevelopmentNOK 1.2m
- Mr. Hakon GrotheChief Innovation Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medistim ASA is a leading medical technology company specializing in advanced surgical imaging and detecting solutions.
- The company has a strong reputation for delivering high-quality and reliable products, which has resulted in a loyal customer base.
- Medistim ASA has a robust research and development (R&D) department that continually innovates and introduces new and improved products to meet evolving customer needs.
Weaknesses
- One potential weakness of Medistim ASA is its heavy dependence on the global healthcare industry, which is subject to regulatory changes and economic downturns.
- The company may face challenges in terms of effectively marketing its products and expanding its market share, especially in highly competitive regions.
- Medistim ASA may also have limited resources compared to larger competitors, which could restrict its ability to invest in extensive marketing campaigns or acquire smaller companies.
Opportunities
- The growing global healthcare expenditure presents an excellent opportunity for Medistim ASA to increase its market share and revenue.
- The company can leverage advancements in digital health technology to develop innovative surgical imaging and detecting solutions, expanding its product portfolio and attracting new customers.
- There is a rising demand for minimally invasive surgical procedures, and Medistim ASA can capitalize on this trend by offering products that enable accurate and efficient surgical interventions.
Threats
- Intense competition in the medical technology industry poses a threat to Medistim ASA's market position and profitability.
- Regulatory requirements and compliance can be challenging for Medistim ASA, and any failure to meet these standards could result in product recalls or legal issues.
- Global economic downturns or reduced healthcare spending in certain regions could significantly impact Medistim ASA's revenue and growth prospects.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.